Calisto 50 Units (Calidinohgenase)

Adult dose

Administer 30~150 I.U. orally in 3 divided doses daily. Adjust the dose as appropriate according to age and symptoms.

This medication should not be used in patients with bleeding conditions, such as those who have just experienced a cerebral hemorrhage. Additionally, this medication contains lactose, so it should not be administered to patients with genetically confirmed galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption syndrome. When using this medication, hypersensitivity symptoms such as rash or itching may occur; if such symptoms arise, use should be discontinued immediately. Symptoms like palpitations may rarely occur as cardiovascular anomalies. Gastrointestinal symptoms such as discomfort in the upper abdomen, nausea, vomiting, loss of appetite, upper abdominal pain, diarrhea, and constipation may also occasionally appear. Additionally, symptoms like fever, headache, feelings of heaviness in the head, drowsiness, and fatigue may be experienced rarely. In elderly patients, due to potential weakness in body functions, special care should be taken such as reducing the dosage when using this medication.

• Rash
• itching
• palpitations
• discomfort in the stomach
• nausea
• vomiting
• loss of appetite
• abdominal pain
• diarrhea
• constipation

This medication should be stored in a tightly sealed container to keep air and moisture out and should be kept at a temperature between 1 degree and 30 degrees Celsius at room temperature. Proper storage will help maintain the drug's effectiveness over time.

Appearance

Red, round enteric-coated film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle